Kraig Biocraft Laboratories, Inc.
KBLB
$0.0798
-$0.0002-0.25%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.53% | -17.51% | -12.19% | -46.00% | -36.90% |
| Total Depreciation and Amortization | 150.93% | 91.02% | 93.51% | 27.70% | -37.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.50% | 1.65% | -14.80% | 527.57% | 518.72% |
| Change in Net Operating Assets | 4.48% | 2.27% | -16.27% | 31.25% | 101.95% |
| Cash from Operations | -8.86% | -33.29% | -47.78% | -21.78% | 1.16% |
| Capital Expenditure | -25.00% | 34.38% | 34.38% | 100.00% | -28.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -91.48% | -- | -- | -- | 200.00% |
| Cash from Investing | -91.91% | 34.38% | 34.38% | 100.00% | 199.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 91.33% | 66.33% | 41.33% | 16.33% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,501.83% | 330.00% | 41.33% | 16.33% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -969.07% | -17.47% | -43.31% | -19.21% | 102.50% |